Mvision AI Oy radiology AI products

Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Which exact product, version and licensed modules are in the current offer?
Do related FDA submissions document the same scope, or different functions and versions?
Which costs, support obligations and local acceptance tests remain unresolved?

Prepare with a buyer guide:

Radiology AI pricing and total cost of ownership

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K250064

Dose+ (1.0)

Mvision AI Oy

Authorized purpose: Dose+ 1.0 uses locked machine-learning models to predict a patient-specific three-dimensional dose distribution for men receiving external-beam radiotherapy for localized prostate cancer or prostate cancer with pelvic-node involvement. Qualified users must review its DICOM RT Dose output in a treatment-planning system or compatible viewer.

Modality: Radiotherapy Planning Imaging
Anatomy: Prostate/Pelvis
Decision: 2025-09-04

Radiotherapy planning Prostate imaging

FDA-cleared K241490

Contour+ (MVision AI Segmentation)

MVision AI Oy

Authorized purpose: Contour+ generates initial CT and MR anatomical contours across head and neck, brain, breast, thoracoabdominal, and pelvic radiation-treatment planning workflows for qualified review and approval.

Modality: Radiotherapy Planning Imaging
Anatomy: Multi-region
Decision: 2024-10-18

Breast imaging Radiotherapy planning